Ashley Graham Sees GLP-1 Drugs as Body Positivity Reversal

Ashley Graham, the prominent model and body positivity advocate, has described the rising popularity of GLP-1 weight loss medications as a disheartening reversal for the movement she has long championed.

In an interview with Marie Claire published April 30, the 38-year-old mother of three addressed drugs such as Ozempic, Wegovy and Mounjaro, which are approved for managing type 2 diabetes and, in some cases, weight loss by mimicking hormones that regulate blood sugar and appetite. Graham, who made history as the first plus-size model on the cover of Sports Illustrated Swimsuit Issue in 2016, said the trend feels like "a smack in the face to the women who have felt like they've had a voice."

"There was a pendulum that swung that was so body acceptance, positivity, everybody be who they want to be. And now it's going back this whole opposite way," she told the magazine. Graham acknowledged the medications reflect current cultural shifts but emphasized they will not eliminate diversity in body types. "It goes with the times and GLP-1s are a time. I know that there are, and there's gonna still be women who are considered plus size forever. This drug isn't going to wipe out a whole...